Fundraising to advance development of targeted polymer nanoparticle platform with applications for medical diagnostics.
DIAGNOSTICS FOR CHRONIC & INFECTIOUS DISEASE
An opportunity for quantitative serological assay development for biomarkers and neutralizing antibodies.
Applications for assaying protective neutralizing antibodies would allow patients to track the status of their neutralizing antibody titers following vaccination or infection and help contain the spread of infectious diseases (e.g., SARS-CoV-2 (COVID)).
Standardization of chemistry platform for quantitative studies could be a transformative detection tool in responding to disease outbreaks.
Contact us for more information regarding investment or collaboration opportunities.